Lfa Lugano Financial Advisors Sa Gilead Sciences, Inc. Transaction History
Lfa Lugano Financial Advisors Sa
- $130 Million
- Q2 2024
A detailed history of Lfa Lugano Financial Advisors Sa transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Lfa Lugano Financial Advisors Sa holds 150 shares of GILD stock, worth $13,212. This represents 0.01% of its overall portfolio holdings.
Number of Shares
150
Previous 150
-0.0%
Holding current value
$13,212
Previous $10,000
-0.0%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
1,893Shares Held
1.02BCall Options Held
12MPut Options Held
9.04M-
Black Rock Inc. New York, NY121MShares$10.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.2 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.72 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.32 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.23 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $110B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...